Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2523f709be3a0d6

Jump to content

Solopharm

From Wikipedia, the free encyclopedia

Solopharm (Grotex OOO) is a Russian pharmaceutical company that produces liquid sterile dosage forms according to GMP standards (license No. 00023-LS).[1] The company manufactures infusion and injection solutions, ophthalmic, otolaryngological, gastroenterological, rheumatological and cosmetological products.

History

[edit]

Solopharm was established in 2010 by Russian businessman, Oleg Zherebtsov.[2] In August 2014, the company launched injection and infusion solution technology Blow-Fill-Seal.[3] Solopharm company continues building and assembling new lines to increase the amount of liquid medicines in ophthalmology, otolaryngology, gastroenterology, rheumatology and cosmetology.[4]

Activity

[edit]

The company activity is directed to development and production of:

  • Products in polyethylene and polypropylene packaging
  • Generics in different therapeutic areas
  • Own brands of drugs and medical products

Product Lines

[edit]
  • Ophthalmology
  • Rheumatology
  • Otolaryngology
  • Pulmonology
  • Cosmetology
  • Gastroenterology
  • Injection solutions
  • Infusion solutions

References

[edit]
  1. "Фармзавод Solopharm инвестирует 32 млн евро в строительство третьей очереди". Фармацевтический вестник. 2015-09-22. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
  2. Елена Кром, Наталья Доброва (2015-05-15). "О.Жеребцов: от продуктового ретейла до производства вакцин". РБК. Archived from the original on 2016-03-05. Retrieved 2016-04-16.
  3. Богдан Боколейко (2015-10-05). "Первая конференция компании Solopharm для СМИ. Репортаж канала Санкт-Петербург". Бизнес Петербург. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
  4. "Два инвестиционных проекта получили статус стратегических". Новотека. 2016-01-11. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
[edit]